Overcoming clinical challenges in the management of invasive fungal infections in low- and middle-income countries (LMIC)

Expert Rev Anti Infect Ther. 2023 Jul-Dec;21(10):1057-1070. doi: 10.1080/14787210.2023.2257895. Epub 2023 Sep 12.

Abstract

Introduction: The management of invasive fungal infections (IFIs) in low- and middle-income countries (LMIC) is a serious challenge due to limited epidemiology studies, sub-optimal laboratory facilities, gap in antifungal management training and resources. Limited studies highlighted distinctive epidemiology of IFIs in those countries, and difficulty in distinguishing from closely related infections. To overcome the gaps for appropriate management of IFIs, innovative approaches are required.

Areas covered: Extensive literature search and discussion with experts have helped us to summarize the epidemiology, diagnostic and management difficulties in managing IFIs in LMIC, and recommend certain solutions to overcome the challenges.

Expert opinion: The strategies to overcome the challenges in diagnosis may include local epidemiology study, training of healthcare workers, association of fungal infections with already existing budgeted national programs, development and incorporation of point-of-care test (POCT) for prompt diagnosis, simplifying clinical diagnostic criteria suitable for LMIC, judicious use of available expertise, and diagnostic stewardship. For management strategies judicious use of antifungal, partnering with industry for inexpensive antifungal agents, development of LMIC specific guidelines for cost-effective management of IFIs and fungal outbreaks, improvement of infection control practices, advocacy for implementation of WHO recommended antifungal use, and integration of IFIs with public health.

Keywords: Antifungal Treatment; Invasive fungal infections; antifungal treatment; point-of-care testing; resource limited setting.

Publication types

  • Review

MeSH terms

  • Antifungal Agents / therapeutic use
  • Developing Countries
  • Humans
  • Invasive Fungal Infections* / diagnosis
  • Invasive Fungal Infections* / drug therapy
  • Invasive Fungal Infections* / epidemiology
  • Mycoses* / diagnosis
  • Mycoses* / drug therapy
  • Mycoses* / epidemiology

Substances

  • Antifungal Agents